Literature DB >> 18536477

[Discussion on quality control of preparations with cortex moutan in volume I pharmacopoeia of People's Republic of China (2005 edition)].

You-Qing Tian1, Ping Ding, Xian-Hai Yan, Wen-Jiang Hu.   

Abstract

This article analyzed the quality control of 35 preparations with cortex moutan in volume I pharmacopoeia of People' s Republic of China (2005 edition). The result showed that only 11 preparations selected paeonol in cortex moutan as one of their quality indexes, the others selected other components or none as index. Via discussing problems on quality control in preparations with cortex moutan, it gave some suggestions on index selection for quality control and method selection for the determination of paeonol in preparations with cortex moutan, and provided some references for the revision of pharmacopoeia of People's Republic of China (2005 edition I ).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18536477

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  4 in total

1.  Characteristics analysis of the complete Wurfbainia villosa chloroplast genome.

Authors:  Wenli An; Jing Li; Zerui Yang; Yuying Huang; Song Huang; Xiasheng Zheng
Journal:  Physiol Mol Biol Plants       Date:  2020-03-19

2.  Astragaloside IV attenuates orbital inflammation in Graves' orbitopathy through suppression of autophagy.

Authors:  Hong Li; Yali Zhang; Jie Min; Long Gao; Ren Zhang; Yucheng Yang
Journal:  Inflamm Res       Date:  2017-11-10       Impact factor: 4.575

3.  Molecular mechanism of shikonin inhibiting tumor growth and potential application in cancer treatment.

Authors:  Qiang Wang; Jing Wang; Jiayou Wang; Xiaoli Ju; Heng Zhang
Journal:  Toxicol Res (Camb)       Date:  2021-11-26       Impact factor: 3.524

4.  Protective effects of Salidroside on cardiac function in mice with myocardial infarction.

Authors:  Pengsheng Chen; Jia Liu; Hongyun Ruan; Miaomiao Zhang; Peng Wu; Du Yimei; Bing Han
Journal:  Sci Rep       Date:  2019-12-02       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.